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University College London, London, United KingdomABSTRACT Transthyretin (TTR) amyloidoses are familial or sporadic degenerative conditions that often feature heavy cardiac
involvement. Presently, no effective pharmacological therapy for TTR amyloidoses is available, mostly due to a substantial
lack of knowledge about both the molecular mechanisms of TTR aggregation in tissue and the ensuing functional and viability
modifications that occur in aggregate-exposed cells. TTR amyloidoses are of particular interest regarding the relation between
functional and viability impairment in aggregate-exposed excitable cells such as peripheral neurons and cardiomyocytes. In
particular, the latter cells provide an opportunity to investigate in parallel the electrophysiological and biochemical modifications
that take place when the cells are exposed for various lengths of time to variously aggregated wild-type TTR, a condition that
characterizes senile systemic amyloidosis. In this study, we investigated biochemical and electrophysiological modifications
in cardiomyocytes exposed to amyloid oligomers or fibrils of wild-type TTR or to its T4-stabilized form, which resists tetramer
disassembly, misfolding, and aggregation. Amyloid TTR cytotoxicity results in mitochondrial potential modification, oxidative
stress, deregulation of cytoplasmic Ca2þ levels, and Ca2þ cycling. The altered intracellular Ca2þ cycling causes a prolongation
of the action potential, as determined by whole-cell recordings of action potentials on isolated mouse ventricular myocytes,
which may contribute to the development of cellular arrhythmias and conduction alterations often seen in patients with TTR
amyloidosis. Our data add information about the biochemical, functional, and viability alterations that occur in cardiomyocytes
exposed to aggregated TTR, and provide clues as to the molecular and physiological basis of heart dysfunction in sporadic
senile systemic amyloidosis and familial amyloid cardiomyopathy forms of TTR amyloidoses.INTRODUCTIONIn the past few years, misfolded proteins have been pro-
posed to play a key role in the pathophysiology of several
cardiac diseases in humans, including pathologic cardiac
hypertrophy and dilated and ischemic cardiomyopathies.
Various cardiac stress disorders, including dilated and
hypertrophic cardiomyopathies, have been associated with
the presence of soluble protein oligomers in cardio-
myocytes (CMs) (1). Based on these findings, it has been
suggested that protein misfolding and the ensuing proteo-Submitted April 12, 2016, and accepted for publication September 6, 2016.
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 2016toxicity are important contributors to the establishment
and progression of heart failure, and parallel cardiac
dysfunction as a sort of Alzheimer’s disease of the heart
(2). Such information supports the idea that targeting the
accumulation of misfolded proteins could be beneficial in
patients with heart failure.
Several forms of systemic amyloidosis display congestive
heart failure and a variety of alterations in cardiac electro-
genesis and conduction that contribute considerably to
disease-associated morbidity and mortality (3,4). Human
transthyretin (TTR) is one of the proteins whose amyloid
aggregates are often associated with heart disease. TTR is
a 55 kD homotetramer that is synthesized by the liver
and the choroid plexus, which carries T4 and the retinol-
binding protein in the plasma and cerebrospinal fluid (5).
Cardiomyocyte Effects of TTR AggregatesExtracellular aggregates of wild-type TTR (wtTTR) are
found in senile systemic amyloidosis (SSA), a condition
that affects ~25% of the population over 80 years of age.
A more severe phenotype characterizes familial amyloid
cardiomyopathy (FAC), in which TTR aggregation occurs
as a consequence of a number of described mutations in
the TTR gene (6,7). Presently, an effective therapy against
TTR amyloidosis is still lacking, and the most severe cases
of SSA and FAC can be treated only by liver or heart trans-
plantation. Correspondingly, the molecular and functional
mechanisms underlying wtTTR aggregation and toxicity
in cardiac tissue remain ill defined.
Amyloid aggregation of TTR is preceded by tetramer
destabilization into monomers/dimers with an exposed hy-
drophobic surface and monomer/dimer misfolding, which
results in structural reorganization into amyloid assemblies
(8,9). Most of the known TTR mutations in humans
have been shown to be amyloidogenic, favoring tetramer
destabilization (10), whereas tetramer stabilization, which
occurs in some mutants, such as the stable and nonamyloi-
dogenic Thr119Met, as well as after T4 binding, slows
down the rate of dissociation of the TTR tetramer, thus hin-
dering fibril growth (11). Although numerous studies have
addressed this issue in recent years, the identity of the cyto-
toxic species associated with amyloid disease and TTR
amyloidosis is far from clear. Several studies indicated
that fibril deposition into amyloid aggregates is usually pre-
ceded by the appearance of toxic, low-molecular-weight
oligomeric aggregation nuclei (12,13) that impair cell
viability, notably by altering intracellular ion homeostasis
(14–16), although cell sufferance caused by a nutrient
shortage due to the physical barrier posed by the fibrillar
burden can play an important role as well (17). Accord-
ingly, TTR fibrils, which were previously considered to
be directly responsible for tissue impairment in familial
amyloid polyneuropathy/FAC and SSA, are now thought
to be far less toxic than their unstable oligomeric precur-
sors, which are now considered to be mainly responsible
for cell damage and tissue functional impairment (18). It
has long been thought that the mass of deposited amyloid
fibrils is solely responsible for tissue dysfunction; however,
inflammation, apoptosis, and reactive oxygen species
(ROS) markers characteristic of tissue damage can be de-
tected in human carriers of mutant TTR well before the
appearance of amyloid deposits. These markers have
been associated with amorphous TTR aggregates that can
be observed in the early stages of disease evolution (18).
Nevertheless, a substantial body of experimental evidence
fully demonstrates that amyloid fibrils are capable of
causing cellular death in numerous situations (19–29).
This raises the possibility that the molecular determinants
underlying aggregate cytotoxicity are not always associated
with the same type of species, and that there may well be
oligomers and fibrils with different structural and biophys-
ical properties, and hence with different abilities to interactwith, disassemble, permeabilize, and deregulate the cell
membrane (30). Presently, very little information is avail-
able regarding the biochemical and cell modifications
that occur in CMs exposed to aggregated TTR (31),
whereas much is known about the biochemical alterations
and specific functional (e.g., electrophysiological) abnor-
malities that result from exposure to toxic TTR amyloids
of neuronal cells, with ensuing Ca2þ influx via TRPM8
and NaV1.8 channels (14). Furthermore, the possible
involvement of specific lipid clusters in these modifications
was inferred on the basis of some perturbation of
Ca2þconductance (15). Both mechanisms are potentially
relevant for CMs.
In this study, we used HL-1 and primary mouse CM cul-
tures exposed to aggregated wtTTR to investigate aggre-
gate-cell interactions and the ensuing electrophysiological
and biochemical modifications that result in cell functional
and viability impairment. In particular, after performing a
careful biophysical characterization of TTR aggregation
in vitro, we investigated some electrophysiological alter-
ations that occurred after cell exposure to TTR aggregates
that recapitulate, in vitro, specific and crucial aspects of
SSA. Our goal was to provide a complete picture of the
cellular biochemical, functional, and viability impairments
caused by wtTTR at different stages of aggregation. As
far as we know, our findings are the first to be reported
regarding the biochemical and electrophysiological modifi-
cations that occur in CMs exposed to amyloid aggregates of
wtTTR. Our data provide novel, to our knowledge, insights
into the molecular and functional basis of heart pathophys-
iology in TTR amyloidosis.MATERIALS AND METHODS
wtTTR production
Recombinant wtTTR was produced in a bacterial expression system using
the Escherichia coli BL21B DE3 (pLysS) strain. The expressed protein was
purified by gel filtration and ion exchange chromatography, and its purity
was checked with the use of agarose gel and SDS-PAGE. Native, T4-stabi-
lized wtTTR (TTR-T4) was obtained by adding T4 to the wtTTR solution.
Briefly, T4 was dissolved in DMSO (Sigma-Aldrich, St. Louis, MO) at a
1.0 mM concentration for 1 h at room temperature. The solution was
then diluted in PBS containing wtTTR to a TTR-T4 ratio of 1:2. TTR
oligomers (TTR-ol) and fibrils (TTR-fib) were generated by TTR incuba-
tion in 100 mM acetate buffer, pH 4.4, at 25C for 24 h or 96 h, respectively.
In all experiments, aggregate concentration was expressed as the soluble
tetramer concentration.Congo Red assay and Fourier transform-infrared
analysis
Fibril growth was followed via Congo Red (CR) assay and Fourier trans-
form-infrared (FT-IR) analysis. The former was performed by mixing
133 mL of the protein solutions with 867 mL of a 10 mM phosphate buffer,
pH 7.4, solution containing 20 mM CR and 150 mM NaCl. Solutions
without protein or without CR were also prepared as controls. The CR
absorption spectra were acquired after 2–3 min of equilibration using anBiophysical Journal 111, 2024–2038, November 1, 2016 2025
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ments, Centerville, Virginia).
The FT-IR spectra were collected via attenuated total reflection on a pro-
tein-hydrated film using a standardized approach (32,33). Briefly, 3.0 mL
sample aliquots were deposited on the singe reflection diamond plate of a
Golden Gate attenuated total reflection device (Specac Kent, Orpington,
UK) and the spectra were collected after the solvent evaporated. A
670-IR spectrometer (Varian Australia, Mulgrave, Australia) equipped
with a nitrogen-cooled mercury cadmium telluride detector and an air dryer
purging system was used under the following conditions: 2.0 cm1 spectral
resolution, 25 kHz scan speed, 1000 scan coadditions, and triangular
apodization. The second derivatives of the measured spectra were obtained
by the Savitsky-Golay method using the Resolutions-Pro software
(Varian Australia). The FT-IR spectrum of soluble TTR was collected at
a 40 mM protein concentration in 30 mM sodium phosphate buffer,
pH 7.4. For aggregation studies, the TTR spectra were recorded at a
20 mM protein concentration in 100 mM acetate buffer, pH 4.4.Dynamic light-scattering analysis
The size distributions of the protein samples by volume were obtained after
sample centrifugation (18,000 rpm for 10 min). The data were obtained by
means of a Zetasizer Nano S dynamic light-scattering (DLS) device
(Malvern Instruments, Worcestershire, UK) using low-volume disposable
cells (12.5  45 mm). The temperature was maintained at 25C by a ther-
mostated system. The acetate buffer was filtered immediately before use to
clean off any impurity.Atomic force microscopy and transmission
electron microscopy analyses of TTR aggregates
For atomic force microscopy (AFM), a 10 mL aliquot of the sample was
deposited on a freshly cleaved mica substrate and dried under mild vac-
uum. The AFM images were acquired in tapping mode in air using a
Dimension 3100 SPM equipped with a G scanning head (maximum
scan size 100 mm) and driven by a Nanoscope IIIa controller, or a Multi-
mode SPM equipped with an E scanning head (maximum scan size 10
mm) driven by a Nanoscope IV controller (Digital Instruments, Bruker,
Karlsruhe, Germany). Single-beam, uncoated silicon cantilevers (type
OMCL-AC160TS; Olympus, Tokyo, Japan) were used. The drive fre-
quency was in the 290–330 kHz range and the scan rate was in the
0.5–1.0 Hz range.
For transmission electron microscopy (TEM) analysis, sample aliquots
were withdrawn from the aggregation mixture at regular time intervals to
monitor the assembly process after adsorption onto formvar/carbon-coated
400 mesh nickel grids (Agar Scientific, Stansted, United Kingdom) and
negative staining with 2.0% (w/v) uranyl acetate (Sigma-Aldrich). The
grids were observed at a 15–30,000magnification in a JEM (LabWrench,
Ontario, Canada) 1010 transmission electron microscope with an 80 kV
excitation voltage.Dot-blot assay
For the dot-blot assay, 5.0 mL samples of 10 mMwtTTR were spotted onto a
nitrocellulose membrane and left to dry. Then the membrane was blocked
with 3.0% bovine serum albumin, 0.1% Tween-20 in TBS (50 mM Tris-
HCl buffer, pH 7.5, 150 mMNaCl) for 1.0 h at room temperature, and incu-
bated overnight at 4C with rabbit anti-TTR polyclonal antibodies (1:2000)
and with conformation-specific antibodies (rabbit anti-oligomer (A11;
1:10000) or rabbit anti-fibril (OC; 1:5000) polyclonal antibody). After three
washes in TBS/0.1% Tween-20, the membrane was incubated for 1.0 h at
room temperature with peroxidase-conjugated anti-rabbit or anti-mouse
antibodies (1:10,000). After three washes in TBS/0.5% Tween-20, immuno-2026 Biophysical Journal 111, 2024–2038, November 1, 2016detection was performed using the SuperSignal West Pico chemilumines-
cent substrate (Thermo Fisher Scientific, Waltham, MA) and Kodak
Biomax MS film (Sigma-Aldrich, Saint Louis, Missouri).HL-1 CM and human dermal fibroblast a cell
culture
HL-1 CMs were obtained from Dr. W.C. Claycomb (Louisiana State Uni-
versity) and grown in T25, gelatin/fibronectin-coated flasks as previously
described (34). The cells were maintained in Claycomb medium (JRH
Biosciences, Sigma-Aldrich, Saint Louis, Missouri) supplemented with
10% fetal bovine serum (Life Technologies, Monza, Italy), 2.0 mML-gluta-
mine (Life Technologies), 0.1 mM noradrenaline (Sigma-Aldrich), and
100 units/mL penicillin-streptomycin (Life Technologies). At confluence,
the cells were detached and replated at a 1:3 dilution in a new T25 flask
or in 96-well plates and used for experimental measurements. Human
dermal fibroblast a (HDFa) cells were cultured at 37C in complete
medium (Dulbecco’s modified Eagle’s medium (DMEM), 10% fetal bovine
serum, 3.0 mM glutamine, 100 units/mL penicillin and 100 mg/mL
streptomycin) in a humidified, 5.0% CO2 incubator. Every 3 days, the cells
(70–90% confluent) were detached and replated at a 1:3 dilution in a new
plate or in 96-well plates and used for measurements.Isolation of mouse ventricular myocytes
Left ventricular CMs were isolated from adult C57/6BL mice (Charles
River, Wilmington, MA) by enzymatic digestion. Briefly, after heparin in-
jection (5000 units/mL) and anesthesia with isoflurane, the heart was
rapidly excised, mounted on a Langendorff apparatus, and perfused with
perfusion buffer (see solutions) prewarmed at 37C and equilibrated with
100% O2. Then, the solution was quickly changed to perfusion buffer
plus Liberase DL (0.05 mg/mL; Roche Diagnostics, Indianapolis, IN) and
CaCl2 (12.5 mM). The left ventricle was excised, minced, and stirred in
perfusion buffer containing CaCl2 (12.5 mM) and bovine serum albumin
(1.0 mg/mL; Sigma-Aldrich). The CMs were collected by gravity sedimen-
tation and stored in Tyrode’s solution containing 0.5 mM CaCl2 and 4.0%
penicillin-streptomycin solution at room temperature. All recordings were
completed within 4–6 h from the time of cell isolation.Calcium imaging
Intracellular Ca2þ handling was evaluated as previously described (35).
Briefly, HL-1 and mice ventricular CMs were incubated for 20 min at
37C in Tyrode’s solution containing 1–5 mL/L fluo-3-acetoxymethyl ester
(FLUO-3 AM; Molecular Probes, Eugene, OR) and 1.0 mL/mL Pluronic
F127 solution (Molecular Probes) for dye loading. The preparation was
set in the stage of a fluorescence microscope (DMIRE2; Leica, Mannheim,
Germany) properly equipped for fluorescence signal production and detec-
tion. Fluo-3 was excited with the light of a xenon lamp (LPS 220; Photo
Technology International, HORIBAUK, Middlesex, UK), using a bandpass
filter set at 480 5 15 nm. Fluo-3 fluorescence was detected at 540 5
15 nm. Ca2þ release from sarcoplasmic reticulum (SR) stores was studied
using 5.0 mM ryanodine (Rya; Tocris Bioscience, Ellisville, MO) or 5.0 mM
2-aminoethyl diphenylborinate (2-APB; Sigma-Aldrich) to block the Rya
and IP3 receptors, respectively. CMs were preincubated with the inhibitors
for 15 min before recordings were obtained. Experimental control of fluo-
rescence acquisition was performed using the software ImagingWorkbench
(INDEC BioSystems, Santa Clara, California). Data analysis was carried
out using the Axon Imaging Workbench program (v2.2.1; Axon Instru-
ments, Foster City, California) or Metafluor (Molecular Devices, Sunny-
vale, CA). Ca2þ cumulative content was evaluated in HL-1 CMs as the
integrated area under the curve after 20 min of exposure to experimental
conditions and reported as the mean fractional variation (mean 5 SE)
Cardiomyocyte Effects of TTR Aggregateswith respect to the vehicle. Ventricular CMs were paced at 1.0 Hz 1–5 V
(pulse duration 1.0 ms) and the Ca2þ transients were analyzed to calculate
the amplitude, baseline level, time to peak, and 50% and 90% decay times.
The data were reported as mean fractional variation (mean5 SE) relative
to the initial values measured for individual cells.Patch-clamp recordings
Electrophysiological recordings were performed as previously described
(36). The cells were placed in a thermostatic bath on the platform of an in-
verted microscope (Diaphot TMD; Nikon, Kawasaki, Japan). The patch-
clamped cell was superfused by means of a temperature-controlled
(36 5 0.5C) microsuperfuser, allowing rapid changes of the cell-bathing
solution. Action potentials were recorded using a patch amplifier (Axopatch
200B; Molecular Devices) in whole-cell configuration (current clamp
mode) at 1.0 Hz and the signals were digitized via a DAC-ADC interface
(Digidata 1200B; Molecular Devices) acquired by means of pClamp soft-
ware (version 10; Molecular Devices), and analyzed using Origin 7.5
(GraphPad Software). The patch-clamp pipettes, prepared from glass
capillary tubes (borosilicate GC150T; Harvard Apparatus, Saint Laurent,
Canada) by means of a two-stage puller (P-97; Sutter Instrument, Novato,
CA), displayed a resistance of 3.5–5.0 MU when filled with the internal
solution. During the patch-clamp experiments, TTR aggregates were added
to the internal pipette solutions.
The following solutions were used for calcium imaging and
electrophysiology:
 Perfusion buffer (mM): NaCl 113, KCl 4.7, KH2PO4 0.6, Na2PO4 0.6,
MgSO4 1.2, NaHCO3 12, KHCO3 10, HEPES 10, taurine 30, BDM 10,
D-(þ)-glucose 10, pH 7.30.
 Tyrode’s solution (mM): D-(þ)-glucose 10, Hepes 5.0, NaCl 140, KCl
5.4, MgCl2 1.2, CaCl2 0.0125, pH 7.3.
 Pipette solution (mM): K-aspartate 130, Na2-ATP 5, MgCl2 2.0, CaCl2
5,0, EGTA 11, HEPES-KOH 10, pH 7.2.ROS measurement
Intracellular ROS levels were determined using the fluorescent probe
20,70-dichlorofluorescein diacetate, acetyl ester (CM-H2 DCFDA; Thermo
Fisher Scientific/Molecular Probes). CM-H2 DCFDA is a cell-permeant in-
dicator for ROS that becomes fluorescent upon removal of the acetate
groups by intracellular esterases and subsequent oxidation. The latter modi-
fication can be detected by monitoring the increase in fluorescence at
538 nm. The HL-1 cells were plated at a density of 10,000 cells per well
on 96-well plates. After 24 h of cell exposure to the aggregates (10 mM
TTR monomer concentration), 10 mM DCFDA in DMEM without phenol
red was added. After 30 min, the fluorescence values at 538 nm were de-
tected with the use of a Fluoroskan Ascent FL (Thermo Fisher Scientific/
Molecular Probes).Cell viability assay
The cytotoxicity of the different forms of soluble or aggregated TTR was
assessed via a 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bro-
mide (MTT) reduction inhibition assay. Briefly, the cells were plated at a
density of 1500 cells/well on 96-well plates in 100 mL of culture medium.
After 48 h, the medium was changed with 100 mL of fresh medium contain-
ing the different TTR aggregates (10 mM monomer concentration) or with
an equal volume of aggregation buffer (control cells). After 24 h, the cells
were incubated for 2.0 h with 100 mL of serum-free DMEM without phenol
red, containing 0.5 mg/mL MTT. Finally, 100 mL of cell lysis solution
(20% SDS, 50% N,N-dimethylformamide) was added to each well. After
sample incubation at 37C to allow complete lysis, the blue formazanabsorbance was read at 570 nm with an automatic plate reader (Bio-Rad,
Life Science, Segrate, Italy). Cell apoptosis was detected by using the
Annexin V-FITC apoptosis detection kit (Sigma-Aldrich). A propidium io-
dide (PI) solution with Annexin V-FITC was used to discriminate among
viable, apoptotic, and secondary necrotic cells. Briefly, after a 24 h treat-
ment with the TTR aggregates, the cells were incubated with Annexim
V-FITC and PI for 10 min at room temperature. The cells were then
analyzed by flow cytometry, and cell viability was determined using the
Trypan Blue exclusion method. HL-1 cells were treated with TTR aggre-
gates, and after 24 h they were centrifuged at 200  g and incubated in
0.2% Trypan Blue (Sigma-Aldrich) for 10 min at 37C. The cells were
then washed in PBS and counted via phase-contrast microscopy. In this
assay, blue cells were considered to have lost membrane integrity and
were scored as nonviable. All counts were performed in triplicate.Sialic acid cleavage and quantification
The sialic acid moiety was removed from gangliosides as previously
described (37). Briefly, the cells were starved by incubation with DMEM
serum-free media for 3.0 h at 37C and then left standing for 2 h in the pres-
ence of a mixture of neuraminidases (NAM) from Vibrio cholerae
(11.7 mU) and Clostridium perfringens (100 mU; Sigma-Aldrich). The
removed sialic acid was measured enzymatically using a specific kit (Roche
Molecular Biochemicals, Mannheim, Germany) according to the manufac-
turer’s instructions.Mitochondrial membrane potential in living cells
Changes in the mitochondrial membrane potential (DJM) in TTR-exposed
cells (10 mM TTR monomer concentration) were detected by a fluores-
cence-based assay. The cells were cultured for 10 min at 37C on coverslips
in DMEM containing 5.0 mg/mL of the lipophilic cationic probe (fluoro-
chrome(5,5,6,6-tetrachloro-1,1,3,3-tetraethylbenzimidazolcarbocyanine io-
dide) (JC-1 stain; Thermo Fisher Scientific). At a hyperpolarized
mitochondrial membrane potential (140 mV), this dye forms a red fluo-
rescent J-aggregate, whereas at a depolarized membrane potential
(100 mV) it remains in the green fluorescent monomeric form. Before
detection, the cells were washed in PBS and placed in an open slide-flow
loading chamber mounted on the stage of a confocal scanning microscope
(Bio-Rad) equipped with a krypton/argon laser source. The emitted fluores-
cence was monitored at 488 nm and 568 nm with a Nikon plan ApoX60
oil-immersion objective. Series of optical sections (512  512 pixels)
were taken through the depth of the cells with a thickness of 1.0 mm at in-
tervals of 0.8 mm. Twenty optical sections for each sample were projected as
a single composite image by superimposition.Confocal immunofluorescence
Subconfluent HL-1 cells grown on glass coverslips were exposed to 10 mM
TTR aggregates (monomer concentration) for 24 h. After incubation, the
cells were washed with PBS and fixed in 2.0% buffered paraformaldehyde
for 10 min. Then, the cells were counterstained with 50 mg/mL tetrame-
thylrhodamine-conjugated wheat germ agglutinin (Thermo Fisher Scienti-
fic/Molecular Probes) for 45 min at room temperature, permeabilized by
treatment with acetone at 20C for 1.0 min, washed with PBS, and
blocked with PBS containing 0.5% bovine serum albumin and 0.2% gelatin.
After counterstaining, the cells were incubated for 1.0 h at room tempera-
ture with an anti-TTR rabbit polyclonal antibody or with an anti-oligomer
rabbit polyclonal antibody (A11) diluted to 1:1000 and 1:10,000,
respectively, in the blocking solution and then washed with PBS for
30 min under stirring. The immune reaction was revealed by Alexa488 or
Alexa568-conjugated anti-rabbit secondary antibody (Thermo Fisher
Scientific/Molecular Probes) diluted 1:400 in PBS. Finally, the cells wereBiophysical Journal 111, 2024–2038, November 1, 2016 2027
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cifically bound antibody.
Cell-surface monosialotetrahexosylganglioside (GM1) labeling was per-
formed by incubating the cells with 10 ng/mL Alexa488-conjugated cholera
toxin B (CTX-B) in complete medium for 20 min at room temperature. Cell
fluorescence was imaged using a confocal TCS SP5 scanning microscope
(Leica) equipped with a HeNe/Ar laser source for fluorescence measure-
ments. The observations were performed using a Leica Plan Apo X63 oil
immersion objective, suited with optics for differential interference contrast
acquisition. Series of 0.5-mm-thick optical sections (1024  1024 pixels)
were taken through the cell depth at 0.4 mm intervals and 20 optical sections
for each examined sample were Z projected. To quantify the immunofluo-
rescence intensity of cell-associated TTR, we randomly selected 10 fields
of view from three separate experiments. Colocalization analysis was per-
formed by using developed algorithms such as Mander’s overlap coefficient
and the colocalization coefficients k1 and k2 (38):
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S1i , S2iffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiP
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P
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P
i
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;
where S1 and S2 represent the signal intensity of pixels in channels 1 and 2,
respectively.FIGURE 1 Characterization of wtTTR by FT-IR. (A) FT-IR absorption
spectra of native TTR and of TTR incubated at pH 4.4 for different time
lengths. (B) Second derivatives of the absorption spectra reported in (A).
(C) Second derivatives of the absorption spectra of TTR incubated at pH
7.4 for different lengths of time. The peak positions of the main components
are also given. The spectra are reported after normalization to the Amide IData analysis and statistics
Statistical analysis was performed by means of the Prism program (Graph-
Pad software), using Student’s t-test for grouped data or analysis of variance
(ANOVA) followed by Tukey’s multiple-comparisons test for all other
values. A p-value of <0.05 was considered significant.band area. (D) Peak positions (taken from the second derivative spectra) of
the main b-sheet component reported versus incubation time at pH 7.4 or
pH 4.4.RESULTS
Morphological analysis and biophysical
properties of wtTTR aggregates
The wtTTR assemblies TTR-T4, TTR-ol, and TTR-fib,
grown at pH 4.4 for different incubation times, were first
characterized by spectroscopic and morphological ana-
lyses. The conformational properties of TTR-T4 and aggre-
gated TTR were initially investigated at pH 7.4 by FT-IR
spectroscopy, which allows one to study protein secondary
structure and aggregation by analyzing the IR absorption
spectrum in the Amide I region (1700–1600 cm1). TTR-
T4 displayed the Amide I maximum around 1630 cm1
(Fig. 1 A), a signal that resulted from the intramolecular
b-sheet structure of the native protein (28). The second de-
rivative of the spectrum (Fig. 1 B) revealed additional com-
ponents at ~1691 cm1, ~1675 cm1, and ~1649 cm1,
which could be assigned to b-sheets, turns/b-sheets, and
a-helical/random coil structures, respectively. At pH 4.4,
the wtTTR fibrillized. Under these conditions, after
~3 min the peak at 1630 cm1 assigned to the intramolec-
ular b-sheet component slightly decreased in intensity and
shifted to higher wave numbers (Fig. 1, A and B), suggest-2028 Biophysical Journal 111, 2024–2038, November 1, 2016ing partial unfolding/misfolding of the TTR secondary
structures, as previously reported for other proteins
(32,39). Prolonged incubation at pH 4.4 resulted in the
appearance of a downshift of the main b-sheet component,
indicating some rearrangement of the b-sheet contacts in
the growing aggregates. After 96 h of incubation, the
TTR spectrum displayed both a narrower Amide I band
(as compared with that of the natively folded protein,
whose maximum downshifted to ~1624 cm1) and a new,
well-resolved component at ~1692 cm1, characteristic of
intermolecular b-sheets in amyloid fibrils (40,41). These
modifications of the FT-IR spectra of wtTTR were not
found at pH 7.4, where the spectra collected at different
times of incubation were almost superimposable with that
obtained at T0 without any apparent changes (Fig. 1 C),
indicating protein stability. The different behaviors of
wtTTR at pH 4.4 and pH 7.4 were more evident when
the peak position of the main b-sheet component was
plotted against time (Fig. 1 D), since the plot was sharply
modified only at the acidic pH.
Cardiomyocyte Effects of TTR AggregatesIn the first 24 h of TTR incubation at pH 4.4, AFM and
TEM imaging (Fig. 2, A and B) showed the presence of
different-sized oligomeric structures (TTR-ol, 2.7 5
0.1 nm high) coexisting with short, worm-like prefibrillar
assemblies (3.5 5 0.1 nm high). These protofibrils dis-
played a nodular morphology, resembling short chains of
beads. Amyloid fibrils (TTR-fib) were not present at this
aggregation time. Fibrils 5.7 5 0.1 nm in height appeared
later, after 96 h of protein incubation.
The transition from natively folded to oligomeric TTR
was also investigated via DLS. An apparent hydrodynamic
diameter (Dhapp) of ~7.0 nm was found for TTR-T4, which
was consistent with its tetrameric structure (Fig. 2 E) (42).
However, after wtTTR incubation for 24 h at acidic pH,
larger oligomeric forms with a Dhapp of ~1000 nm appeared,
and became prevalent with increasing time (Fig. 2 E).
To further investigate the nature of the oligomeric and
fibrillar structures grown under these conditions,we analyzed
the aggregated TTR samples by immunoblotting using the
oligomer-specific A11 antibody and the fibril-specific OC
antibody. The A11 antibody immunostained both the TTR-
ol and, to a lesser extent, TTR-fib samples, but only TTR-
fib showed a significant OC immunoreactivity. In contrast,
TTR-T4 did not exhibit any immunoreactivity with either
the A11 or OC antibody (Fig. 2 C). The amyloid nature of
TTR-ol and TTR-fib was further confirmed by the red shift
of the CR absorbance maximum, a signature of the amyloid
fold (Fig. 2 D). The shift was not observed in the TTR-T4
incubated under the same conditions (data not shown).Immunolocalization of TTR aggregates
After having described the structural features of TTR, both
natively folded (TTR-T4) and under aggregating conditions
(TTR-ol, TTR-fib), we sought to determine whether these
different TTR species were able to interact with the plasma
membrane of cultured HL-1 cells, and if so, the extent of the
interaction. When the cells were exposed to the stabilized
TTR-T4, we failed to detect any protein interaction with
the cell membrane (Fig. 3 A), in agreement with recently re-
ported data relative to the nonamyloidogenic, stabilized
T119M variant (31). However, a significant association of
TTR aggregates with the cell surface was seen in HL-1 cells
treated with TTR-ol or TTR-fib (Fig. 3, B and C). Contrary
to the case with TTR-fib, TTR-ol was found to be signifi-
cantly internalized into these cells after 24 h of exposure,
as shown by a representative magnified Y projection of a
cell: TTR-fib was only observed in contact with the outer
surface of the cell membrane (Fig. 3 E), whereas TTR-ol
was found in the cytoplasm as A11-immunopositive punc-
tate fluorescence (Fig. 3 D). The association of oligomers
and fibrils with the cell membrane was also evident (to a
less extent for the fibril sample) on HDFa, as shown in
Fig. S1 in the Supporting Material, suggesting that TTR
aggregates did not exhibit a distinct cellular specificity.
However, no internalization of oligomeric species was
evident in these cells (Fig. S1).
The role of the monosialoganglioside GM1, a major raft
marker, in promoting aggregate-membrane interaction wasFIGURE 2 Morphological characterization of
TTR aggregates. (A) AFM images of TTR-T4,
TTR-ol, and TTR-fib. Scan size, 1.0 mm. (B)
TEM images of TTR-T4, TTR-ol, and TTR-fib
(scale bar, 200 nm). (C) Dot blotting of TTR-T4,
TTR-ol, and TTR-fib using anticonformational
A11 and OC antibodies. Three replicates were
generated and probed separately by anti-TTR,
A11, and OC antibody. (D) CR absorption spectra
of TTR-T4 (green line), TTR-ol (red line), and
TTR-fib (blue line). (E) DLS analysis of TTR-T4,
TTR-ol, and TTR-fib, showing the volume distri-
bution of the particle apparent hydrodynamic
diameter. To see this figure in color, go online.
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FIGURE 3 Confocal analysis. (A–C) Confocal images of HL-1 cells treated with wtTTR. The cells were exposed for 24 h to 10 mM (A) TTR-T4, (B)
TTR-ol, and (C) TTR-fib. (D and E) Z projections. (F and G) HL-1 cells were pretreated with NAM to reduce sialic acid on the cell surface and incubated
for 24 h with 10 mMTTR-ol (F) and TTR-fib (G). The cells were stained with cholera toxin (green) and then were fixed, permeabilized, and stained with anti-
TTR antibody (red) or A11 antibody (red). (H) Sialic acid quantification. HL-1 cells were treated with 11.7 mUI of V. cholera neuraminidase and 5.0 mUI of
Arthrobacter ureafaciens neuraminidase for 1.0 h at 37C in serum-free medium. The sialic acid levels in the membrane fractions were analyzed enzymat-
ically with the use of a sialic acid quantification kit; *p< 0.05. (I) Quantitative analysis of TTR binding on the cells. Each graph displays the mean values5
SE and a statistical comparison between TTR-T4-treated cells and cells treated as indicated (n ¼ 5; *p < 0.05, p < 0.01, #p < 0.001). To see this figure in
color, go online.
TABLE 1 Colocalization Analysis of TTR Oligomers/Fibrils
and GM1 on the Plasma Membrane of HL-1 Cardiomyocytes
TTR-ol TTR-fib TTR-ol þ NAM TTR-fib þ NAM
Overlap coefficient 0.895 0.899 0.839 0.850
k1/k2 0.855 0.448 3.070 2.56
Sartiani et al.also investigated. In fact, recent data indicate that besides
favoring peptide/protein misfolding and aggregation, GM1
can also mediate the interaction of amyloid assemblies
with the plasma membrane, notably by means of its nega-
tively charged sialic acid component (27). Therefore, to
further elucidate whether our TTR aggregates interacted
with the cell membrane at GM1-rich sites, as well as the
role of the negatively charged sialic acid moiety of GM1,
we carried out confocal fluorescence microscopy experi-
ments using a polyclonal antibody raised against wtTTR.
The cell membrane was counterstained by Alexa 488-conju-
gated CTX-B, a fluorescent probe that binds predominantly
GM1 on the cell membrane. In some experiments, the cells
were treated with a mixture of NAM to specifically cleave
sialic acid residues from the cell surface before aggregate
exposure. For reducing membrane GM1, this treatment is
milder than treating cells with fumonisin or other inhibitors
of GM1 synthesis because it maintains the GM1 backbone
inside the bilayer and therefore does not perturb the mem-
brane lipid order. The treatment caused a significant decline
(~2.5-fold) of the sialic acid on HL-1 cells, as shown in
Fig. 3 H, without affecting cell viability (data not shown).
Under these conditions, we found that the signals of both
TTR-ol and TTR-fib on the cell membrane were signifi-
cantly reduced in NAM-treated cells (Fig. 3, F, G, and I).
The colocalization analysis using the overlap coefficient
did not show significant differences between NAM-treated
and -untreated samples (Table 1). Therefore, the ratio
between the overlap coefficients k1 (weighted overlap of2030 Biophysical Journal 111, 2024–2038, November 1, 2016TTR immunofluorescence (red) to GM1 fluorescence) and
k2 (weighted overlap of GM1 fluorescence (green) to TTR
immunofluorescence) was used to determine the degree of
GM1 recruitment in the colocalization areas (42). The anal-
ysis showed that the k1/k2 ratio was lower in the cells treated
with TTR-fib than in those treated with TTR-ol, suggesting
that TTR fibrils promote higher GM1 recruitment in the co-
localization areas. When the cells were treated with NAM,
the k1/k2 ratio increased but the total TTR immunofluores-
cence signal decreased, as shown in Fig. 3 I, indicating
that in NAM-treated cells, fibril-membrane interactions
and GM1 clustering on the cell membrane were reduced.
Aggregate recruitment to the cell membrane was deeply
dependent on the presence of negatively charged molecules,
notably GM1, whose decrease affected fibril binding much
more than oligomer binding.
Taken together, these data confirm that TTR aggregates
bind at the cell surface, thus favoring oligomer internaliza-
tion. They also suggest that the interaction involves GM1
and occurs preferentially at its negatively charged moiety,
highlighting the importance of electrostatic binding. Finally,
our data agree with previous studies indicating that TTR
Cardiomyocyte Effects of TTR Aggregatesaggregates have a high affinity for synthetic lipid mem-
branes rich in anionic phospholipids (43).Aggregate cytotoxicity
Once we established that different wtTTR aggregates bind
to membrane sites where sialic acid residues, notably those
bound to GM1, are present, and that binding is followed by
internalization in the case of oligomers, we tested whether
such events modulate cell viability and cause distinct bio-
logical effects. Initially, we checked TTR cytotoxicity to
HL-1 cells by performing an MTT reduction assay. As ex-
pected, TTR-T4 was harmless to exposed cells (Fig. 4 A),
in similarity to the stabilized T119M mutant (31), whereas
TTR-ol and TTR-fib displayed significant cytotoxicity, in
agreement with their ability to interact with the plasma
membrane (Fig. 4 A). We also assessed the cytotoxic effect
of TTR aggregates on HDFa cells. These cells, despite the
presence of aggregate on the membrane, were more resistant
to amyloid insult (Fig. S1), suggesting that various cell types
exposed to the same toxic aggregates have different vulner-
abilities. The decreased MTT reduction observed in HL-1
cells was not related to apoptotic or necrotic events (data
not shown), suggesting that after 24 h of exposure to TTR
aggregates, the HL-1 cells showed a significant impairment
of mitochondrial functionality without cell death or acti-
vation of apoptosis. This finding was confirmed by the
ROS-sensitive fluorescent probe CM-H2 DCFDA; in fact,
we found that incubation for 24 h with TTR-ol stimu-
lated ROS production in HL-1 cells and that this effect
was enhanced when the cells were exposed to TTR-fib
(Fig. 4 B). We used the JC-1 dye to further investigate
whether aggregate cytotoxicity is associated with mitochon-
drial dysfunction, as was previously shown for Ab aggre-
gates in Alzheimer’s disease (44). For this purpose, we
used confocal microscopy to assess the effect on the mito-
chondrial membrane potential (Dcm) of HL-1 exposure to
TTR-T4 or to variously aged wtTTR aggregates. We found
a significant yet similar decrease of Dcm in cells exposed toTTR-ol or TTR-fib, but not to TTR-T4 (Fig. 4, C and D), as
shown by the disappearance of red fluorescence and/or the
increase of green fluorescence. In particular, some cells
were devoid of red fluorescence, which indicates the loss
of Dcm and the severity of the cell damage. These data indi-
cate that in HL-1 cells, the cytotoxicity of extracellular TTR
oligomers and fibrils proceeds through adsorption to the
plasma membrane and results in ROS generation and alter-
ation of the mitochondrial membrane potential.Effect of TTR aggregates on cytoplasmic calcium
levels in HL-1 CMs
It was previously reported that both Ca2þ deregulation and
endoplasmic reticulum stress contribute to TTR toxicity to
neuronal cells (15,16). We therefore investigated whether
some acute deregulation of cytoplasmic Ca2þ levels contrib-
uted to early events after the interaction of aggregated
wtTTR with the sarcolemma and subsequent oligomer inter-
nalization. Typical experimental traces detected in quiescent
HL-1 cells (i.e., not exhibiting spontaneous action potentials
and associated intracellular Ca2þ oscillations) are reported
in Fig. 5 A, which shows a slow, progressive increase of
Ca2þ levels during acute cell exposure to the same concen-
tration of either TTR-ol (gray trace) or TTR-fib (black
trace). Under all conditions, the Ca2þ concentration was
sensitive to caffeine, which, as expected, evoked a fast, tran-
sient Ca2þ increase after the depletion of SR stores. The cu-
mulative Ca2þ content was calculated as the integrated area
under the curve recorded for 20 min and expressed as the
fractional variation (mean 5 SE; Fig. 5 B) relative to the
vehicle. The Ca2þ increase was statistically significant
with respect to the vehicle for both TTR-ol and TTR-fib,
but not for TTR-T4 (see Table S1 for a detailed statistical
analysis).
Spontaneous calcium oscillations were observed in nearly
one-third of confluent HL-1 cells exposed to vehicle at 37C
(Fig. 6 A), and as previously reported (44,45), oscillations
appeared irregular in frequency, amplitude, and durationFIGURE 4 Cell viability, ROS levels, and mito-
chondrial dysfunction. (A–C) Cytotoxicity of TTR-
T4, TTR-ol, and TT-fib to human HL-1 cells as
determined by MTT reduction assay (A), intracel-
lular ROS production (B), and JC-1 assay (C).
(D) Quantification of Dcm expressed as a ratio
(J-aggregates/monomer) in the different treatment
groups. The values shown are normalized against
the buffer control (n ¼ 3, mean5 SD). The statis-
tics were analyzed by unpaired Student’s t-test
(**p < 0.01, ***p < 0.001). To see this figure in
color, go online.
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FIGURE 5 Effects of different TTR samples on
cytoplasmic calcium levels in HL-1 CMs. (A) Time
course of cytosolic Ca2þ signals detected in HL-1
CMs exposed to 10 mM TTR-ol or TTR-fib (mono-
mer concentration) for 20 min before SR depletion
with 10 mM caffeine. (B) Mean fractional variation
(5 standard error of the mean) relative to vehicle
of cumulative cytosolic Ca2þ calculated after
20 min of exposure to different experimental condi-
tions. Abbreviations: Veh, vehicle; TTR-ol, oligo-
meric transthyretin; TTR-fib, fibrillar transthyretin;
TTR-T4, native TTR complex with thyroid hor-
mone; TTR-ol 0 Ca, oligomeric TTR in Ca2þ-free
medium; TTR-fib 0 Ca, fibrillar TTR in Ca2þ-free
medium; TTR-ol Rya, oligomeric TTR plus ryano-
dine; TTR-ol 2-APB, oligomeric TTR plus 2-APB;
TTR-fib Rya, fibrillar TTR plus ryanodine; TTR-
fib 2-APB, fibrillar TTR plus 2-APB. The statistical
analysis (ANOVA followed by Tukey’s multiple-
comparisons test) is reported in Table S1.
Sartiani et al.(see inset of Fig. 6 A). The estimated oscillation fre-
quency values were 6.3 5 1.1 beats per minute (bpm) for
cells treated with vehicle (n ¼ 19), 5.45 2.5 bpm for cells
treated with wtTTR (n ¼ 14), and 5.9 5 1.5 bpm for cells
treated with TTR-T4 (n ¼ 15). Notably, the baseline cal-
cium signal remained constant throughout the experimental
interval with the vehicle as well as with wtTTR or TTR-T4
(Fig. 6, B and K). Interestingly, neither TTR-fib nor TTR-ol
produced any gross modification in the oscillation frequency
values (6.3 5 1.2 bpm (n ¼ 11) and 5.6 5 1.5 bpm (n ¼
17), respectively); however, similar to what was observed
for quiescent HL-1 cells, both TTR-fib and TTR-ol clearly
induced a net increase in the baseline calcium signal, indi-
cating a progressive accumulation of cytosolic calcium
(Fig. 6, C and G).
Considering that the increase of cytosolic Ca2þ in olig-
omer- and fibril-exposed cells resulted from aggregate inter-
action with the cell membrane and, possibly, oligomer
internalization, we hypothesized that in cells exposed to
TTR-ol, the internalized species gained access to the Ca2þ
stores in the SR, favoring Ca2þ exit to the cytosol, as was
previously shown for the endoplasmic reticulum in a mouse
neuronal cell line (16). Therefore, we studied whether the
Ca2þ deposits in HL-1 were sensitive to cell exposure to
TTR-ol, TTR-fib, and TTR-T4 by investigating the possible
involvement of the Rya and IP3 receptors, two well-known
SR receptors that regulate Ca2þ handling in CMs. HL-1
cells were preincubated with Rya and 2-APB for 15 min
to block the Rya and IP3 receptors, respectively, before
and during exposure to TTR-ol, TTR-fib, or TTR-T4. Under
these conditions, the increase of intracellular Ca2þ was
significantly reduced (Fig. 5 B; Table S1), suggesting an
involvement of the Rya and IP3 receptors and hence of
the SR Ca2þ stores. In automatic HL-1 cells, spontaneous
calcium oscillations were eliminated by depletion of intra-
cellular calcium stores with Rya and 2-APB (Fig. 6, E–N).
Nonetheless, during Rya or 2-APB treatment, TTR-ol and2032 Biophysical Journal 111, 2024–2038, November 1, 2016TTR-fib were still able to produce a modest yet visible in-
crease of the baseline calcium signal (Fig. 6, E and J),
in line with the effect observed in quiescent HL-1 cells
(Fig. 5 B).
It is known that amyloid oligomers permeabilize the
plasma membrane of exposed cells, favoring uncontrolled
Ca2þ entry from the extracellular milieu either nonspecif-
ically after disassembly of the membrane bilayer (46,47)
and/or through the participation of specific Ca2þ channels
(48,49). Therefore, we removed Ca2þ from the external
solution to check whether and to what extent the CM
plasma membrane, in addition to the SR one, was
involved in the intracellular Ca2þ increase induced by
TTR aggregates. Under these conditions, the increase of
cytosolic Ca2þ in cells exposed to either TTR-ol or
TTR-fib was significantly reduced (Fig. 5 B and Table
S1). Spontaneous calcium oscillations were also elimi-
nated in automatic HL-1 cells by removal of external
Ca2þ (Fig. 6, D–L), in agreement with previous data
(50). Similar to what was observed in the nonautomatic
HL-1 cells (Fig. 5 B), exposure to either TTR-fib or
TTR-ol enhanced the baseline calcium signal (Fig. 6, D
and H). Thus, Ca2þ influx from the extracellular medium
and release from the internal stores both contribute to the
cytoplasmic Ca2þ increase induced by prefibrillar and
fibrillar wtTTR.Effect of TTR aggregates on calcium cycling and
the action potential profile of mouse ventricular
myocytes
The enhanced intracellular Ca2þ levels in cells exposed to
TTR-ol or TTR-fib led us to hypothesize that the presence
of TTR aggregates could alter Ca2þ cycling and the mem-
brane potential during myocyte contraction. To test this hy-
pothesis, we measured Ca2þ transients in mouse ventricular
CMs during contraction evoked by electrical stimulation.
FIGURE 6 Effects of different TTR samples on cytoplasmic calcium levels in automatic HL-1 CMs. (A) Time course of cytosolic Ca2þ signals detected in
automatic HL-1 CMs exposed to vehicle (A), 10 mMTTR (B), TTR-ol (C), TTR-ol in Ca2þ-free medium (D), TTR-ol plus ryanodine (E), TTR-ol plus 2-APB
(F), TTR-fib (G), TTR-fib in Ca2þ-free medium (H), TTR-fib plus ryanodine (I), TTR-fib plus 2-APB (J), TTR-T4 (K), TTR-T4 in Ca2þ-free medium (L),
TTR-T4 plus ryanodine (M), or TTR-T4 plus 2-APB (N) for 20 min before SR depletion with 10 mM caffeine. Abbreviations: Veh, vehicle; TTR-ol, olig-
omeric transthyretin; TTR-fib, fibrillar transthyretin; TTR-T4, native TTR complex with thyroid hormone; TTR-ol 0 Ca, oligomeric TTR in Ca2þ-free me-
dium; TTR-fib 0 Ca, fibrillar TTR in Ca2þ-free medium; TTR-T4 0 Ca, TTR-T4 in Ca2þ-free medium; TTR-ol Rya, oligomeric TTR plus ryanodine; TTR-ol
2-APB, oligomeric TTR plus 2-APB; TTR-fib Rya, fibrillar TTR plus ryanodine; TTR-fib 2-APB, fibrillar TTR plus 2-APB; TTR-T4 Rya, TTR-T4 plus
ryanodine; TTR-T4 2-APB, TTR-T4 plus 2-APB.
Cardiomyocyte Effects of TTR AggregatesAs shown in Fig. 7 A, cell treatment with 10 mM
TTR-ol increased Ca2þ transient amplitudes after 5 min
(b), 10 min (c), and 15 min (d) of exposure. At the same
time, the mean fractional variations of the Ca2þ transient
amplitude (Fig. 7 B) in cells exposed to TTR-ol were
significantly different from those detected in cells exposed
to TTR-T4 or to vehicle. We observed a similar effect in
cells exposed to TTR-fib: the effect arose in the same
time window, but its magnitude was significantly reduced
as compared with that seen in cells exposed to TTR-ol
(see Table S2 for statistical analysis). The reduced magni-
tude was consistent with the smaller cumulative calcium
fractional variation induced by TTR-fib as compared with
TTR-ol in HL-1 cells. This finding agrees with the Ca2þrelease from the internal stores and the Ca2þ flux from
the extracellular medium seen in HL-1 cells (see above).
Other parameters of Ca2þ transient (baseline level, time
to peak, and decay kinetics) were not modified (Tables
S3–S5; Table 2).
Finally, to assess the consequences of the altered intra-
cellular Ca2þ cycling on the membrane potential, we per-
formed whole-cell recordings of the action potential on
isolated mouse ventricular myocytes by adding TTR-ol or
TTR-fib to the pipette solution. Under this condition, a clear
prolongation of the action potential became evident 3 min
after whole-cell access was gained. This persisted after
7 min and was characterized by a marked lengthening of
the plateau phase (Fig. 7 C). The observed effect on theBiophysical Journal 111, 2024–2038, November 1, 2016 2033
FIGURE 7 Effects of TTR variants on the calcium transient and action
potential of mouse ventricular myocytes. (A) Representative fluorescence
signals measured from ventricular CMs loaded with Fluo-4 and stimulated
at a 1.0 Hz pacing frequency during exposure to oligomeric TTR for 0 (a), 5
(b), 10 (c), 15 (d), or 20 (e) min. (B) Time course of Ca2þ transient ampli-
tude variation, expressed as the mean fractional variation (5 standard error
of the mean) relative to the time zero amplitude in ventricular CMs exposed
to vehicle (n¼ 18), TTR-ol (n¼ 13), TTR-fib (n¼ 19), or wtTTR (n¼ 14).
The statistical analysis (ANOVA followed by Tukey’s multiple-compari-
sons test) is reported in Table S2. (C) Representative action potential pro-
files measured from ventricular CMs recorded in whole-cell configuration
(1.0 Hz pacing frequency) immediately after seal rupture (a and d) and after
3 or 7 min of exposure to a pipette solution containing 1.0 mM TTR-ol
(b and c) or TTR-fib (e and f).
Sartiani et al.membrane potential is in line with the increase of cytosolic
Ca2þ reported above and confirms the interference of oligo-
meric and fibrillar TTR with the electrophysiological prop-
erties of the investigated CMs.TABLE 2 The 90% Decay Time Fractional Variation of Calcium Tra
Cardiomyocytes
Time (min) Vehicle (mean5 SE) n ¼ 18 TTR (mean5 SE) n ¼ 1
0 1.1  1065 9.1  107 2.0  107 5 3.1  10
5 15.75 12.3 7.55 8.7
10 13.95 12.0 1.35 10.3
15 30.15 18.0 16.25 10.3
20 122.45 31.4 115.75 25.8
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Cardiomyopathy is the most frequent and severe complica-
tion of TTR amyloidosis in both the familial (FAC) and se-
nile (SSA) forms. The lack of effective pharmacological
treatments for these conditions is due, at least in part, to
the lack of information regarding the key factors underlying
TTR misfolding and aggregation in tissue, as well as
the molecular features of the biochemical, functional, and
viability impairments of cardiac cells exposed to aggregated
TTR. Presently, the cytotoxicity of amyloid aggregates,
particularly those that arise early in the aggregation path,
is considered to be one of the main factors responsible for
cell functional and viability impairments (15,47), although
cell sufferance can also result from the physical barrier to
nutrient exchange posed by fibrillar deposits (51).
In this study, we investigated how different wtTTR forms,
such as the nonamyloidogenic, stabilized T4-bound deriva-
tive and amyloidogenic TTR (including prefibrillar as-
semblies (TTR-ol) and mature fibrils (TTR-fib)) affect the
viability and some biochemical parameters of exposed
CMs. These data were added to those provided by electro-
physiological experiments on the early functional alter-
ations that occur in exposed cardiac cells in terms of Ca2þ
transients and membrane potential. In our experimental
model, the TTR-fib sample contained a heterogeneous
mixture of prefibrillar and fibrillar components as shown
by dot immunostaining. This makes sense if one considers
that cardiac cells are exposed to tissue deposits where
TTR is aggregated in the fibrillar form, and that oligomeric
and/or protofibrils entities can also be present either as in-
termediates in the aggregation path (12,13) and/or after
leakage from the fibrillar deposits, as was previously re-
ported for other aggregated proteins (17).
We initially characterized the aggregated forms used in
this study by investigating in depth the path of TTR aggre-
gation at pH 4.4 or 7.4, as well as aggregate morphology, by
FT-IR, CR, DLS, and AFM. The aggregation of wtTTR, but
not TTR-T4, at pH 4.4 displayed the well-known path,
where early oligomers are progressively replaced by mature
fibrils as long as aggregation proceeds. The protein did not
aggregate at pH 7.4, even during long incubation times, as
was previously reported (15). We then investigated whether,
where, and how the different TTR aggregates were able to
interact with the sarcolemma of the exposed cells. Prefibril-
lar TTR assemblies and TTR fibrils interacted with thensient Relatives to Initial Values in Mice Ventricular
3 TTR-ol (mean5 SE) n ¼ 14 TTR-fib (mean5 SE) n ¼ 19
7 8.3  107 5 1.0  106 4.4  108 5 1.9  107
14.05 12.6 10.45 3.9
17.05 15.3 13.25 5.1
40.25 23.3 25.45 10.9
202.85 81.4 122.35 25.1
Cardiomyocyte Effects of TTR Aggregatesplasma membrane of CMs, and such interactions required
the negatively charged sialic acid moiety of the ganglioside
GM1, a key lipid raft component, although we cannot
exclude some contribution coming from the sialic acid
residues bound to membrane glycoproteins. In this re-
gard, there are some clear qualitative commonalities with
data obtained in other cell types (namely, neurons) and
with aggregates grown from different peptides/proteins: am-
yloid aggregation and aggregate recruitment are favored
by GM1-rich sites of the cell membrane (48,52,53) and,
more generally, by negatively charged surfaces (54–58).
This observation also leads us to speculate that an increase
in GM1 content in aged CMs could favor TTR aggregation
in SSA, as was previously shown in amyloid-positive synap-
tosomes from brains with Alzheimer’s disease (54). How-
ever, as far as we know, no data regarding the GM1
content in aged CMs are available. Under our experimental
conditions, the colocalization analysis showed that the
fibrillar component promoted a higher GM1 recruitment
than the prefibrillar component, suggesting a higher activity
of the fibrils upon cell membrane uptake by raft components
and subsequent membrane damage. Accordingly, a recent
study (30) suggested that amyloid toxicity is mediated by
cellular factors that interact with protofibrils and fibrils,
inducing further protein fibrillization on the cell surface
that in turn triggers a cascade of intracellular events down-
stream that compromise cell survival. The importance of
lipid rafts in TTR recruitment by the plasma membrane of
exposed cells is indirectly confirmed by a recent study in
which Manral and Reixach (31) reported that a reduction
of membrane cholesterol, a key component of lipid rafts,
significantly impaired the interaction and subsequent inter-
nalization of two TTR variants (I122V and T119M) with
the plasma membrane of exposed CMs (the AC16 line).
Although the authors exposed cells to soluble, nonaggre-
gated proteins, they were aware of the difficulty of assessing
precisely which TTR species are involved in cell damage.
They speculated about the possibility that the samples
of their soluble amyloidogenic V121I TTR contained tiny
amounts of oligomer populations that would interact prefer-
entially with the exposed cells. If so, their conditions would
resemble those used in our well-controlled approach.
TTR-ol and TTR-fib displayed significant cytotoxicity,
but they did not result in cell death under our conditions,
in accordance with their abilities to interact with the plasma
membrane, to be internalized (in the case of TTR-ol), to
induce intracellular ROS production, and to alter intracel-
lular Ca2þ homeostasis and the mitochondrial membrane
potential. The latter effects were, at least in part, the conse-
quence of membrane permeabilization to calcium; in fact,
increase in intracellular Ca2þ concentration and mitochon-
drial membrane potential perturbation were not seen in cells
cultured in Ca2þ-free medium or exposed to the stabilized
TTR-T4, which was unable to bind to the plasma mem-
brane. The hampered Ca2þ increase in cells treated with in-hibitors of the Rya and IP3 receptors before exposure to
aggregated TTR suggests that such an increase depends, at
least in part, on the release from SR stores through either re-
ceptor. Similar observations were previously made in mouse
neuronal cells exposed to TTR oligomers (16), suggesting
the existence of shared basic alterations induced by TTR ag-
gregates in different cell types and a possible pathophysio-
logic basis for multiorgan failure in TTR amyloidosis. In
our model, it is possible that the increased Ca2þ initially
came from the extracellular medium and only subsequently
from the intracellular stores by Ca2þ-induced calcium
release, an important mechanism of Ca2þ handling in car-
diac cells (59). We cannot exclude the possibility that the
effects observed at the mitochondrial and SR membranes
result, at least in part, from the interaction with the internal-
ized oligomers; however, the same effects were also found
in cells exposed to TTR-fib, where intracellular oligomers
were absent. More likely, the mitochondrial membrane de-
polarization resulted from the increased levels of free intra-
cellular Ca2þ, as reported in other cases (60). In the case
of TTR-fib, which does not penetrate inside the cells, a
different mechanism, either alternative or additive, can be
hypothesized. This could involve fibril interaction with
death receptors or Ca2þ channels, as was previously shown
for amyloid fibrils grown from Sup35NM (27) or ataxin-3
(48). This scenario supports the idea that in TTR amyloid-
osis, same disturbance of cell/tissue function by the deposits
of fibrillar material results not only from a mechanical alter-
ation of proper oxygen and nutrient exchange, but also from
more subtle biochemical and physiological modifications
resulting from the interaction of deposited fibrils and/or
leaked oligomers with surrounding cells. Several lines of
evidence implicate amyloid oligomers as the main cytotoxic
species, even though not all oligomers are cytotoxic (61,62).
However, the cytotoxicity of amyloid fibrils is not surprising
since it has been reported repeatedly (19–23). In addition,
given the high complexity of the fibrillation process, and
considering the overall dynamics of the assembly and disas-
sembly of toxic amyloid species, the possibility that toxicity
is displayed by different conformers should not be disre-
garded. Moreover, it has also been suggested that the
ongoing aggregation process, rather than a clearly defined
aggregate, is responsible for amyloid toxicity (30,63).
Our findings regarding Ca2þ dyshomeostasis in exposed
CMs reveal the occurrence of early effects, which likely
precede or parallel those that affect cell viability and mito-
chondrial physiology. In cell cultures, all of these effects
developed within minutes from cell exposure to the aggre-
gates, as shown by the temporal dynamics of the Ca2þ levels
and action potential recordings. A similar time course of
cytoplasmic Ca2þ increase was previously observed in pe-
ripheral sensory neurons exposed to TTR aggregates, where
the effects were mediated by a gain of function of different
ion channels, namely, voltage-gated calcium and sodium
channels and transient receptor potential M8 channelsBiophysical Journal 111, 2024–2038, November 1, 2016 2035
Sartiani et al.(14). The question of whether in our setting the enhanced
intracellular Ca2þ resulted from similar modifications de-
serves further investigation. In line with this observation,
our findings regarding the perturbation of intracellular
Ca2þ homeostasis do not exclude (or may also concur
with) the possibility of multiple modifications of different
ion channels and/or pumps, which altogether contribute to
define the functional profile of CMs. However, a compre-
hensive exploration of each specific ionic modification
potentially induced by TTR variants would require dedi-
cated investigations beyond the scope of this study. Interest-
ingly, in sensory neurons, one of the mechanisms that have
been proposed to explain the Ca2þ increase is a TTR inter-
action with cholesterol-rich regions of membranes that are
able to promote ion channel opening. This hypothesis is in
line with previous findings (31,55,64) and with the data pre-
sented here, which show a preferential interaction of TTR
aggregates with GM1-rich sites, presumably in lipid rafts.
Of note, GM1-rich sites have been shown to colocalize
with and modulate ion channel function in the plasma mem-
brane of different cell types (65–70), and with the sodium
calcium exchanger in the nuclear envelope of CMs (71).
Besides cell viability and mitochondrial efficiency, the
increase in Ca2þ transient amplitude observed in elec-
trically stimulated ventricular CMs exposed to TTR ag-
gregates is in agreement with their ability to mobilize
cytosolic Ca2þ. Indeed, in CMs, a complex network
involving plasmalemma, SR receptors (namely, Rya, but
also IP3 receptors), and mitochondria is responsible for
fine-tuning cytosolic Ca2þ (72–74). In this interplay, the
mitochondria serve as an efficient dynamic buffer of the
Ca2þ released during contraction. The interplay that occurs
inside cells among oxidative metabolism, calcium levels,
ATP and ROS production, and protein aggregation was pre-
viously outlined (74). It is possible that ionic mechanisms
that serve this function at the mitochondrial membrane are
impaired by TTR aggregate-induced membrane depolariza-
tion, thus contributing to the cytoplasmic Ca2þ increase.
Regardless of the source of Ca2þ accumulation inside the
CMs, this effect is expected invariably to have relevant
consequences in terms of the generation and propagation
of electrical impulses. Indeed, an increase in intracellular
calcium concentration is a common feature of several ac-
quired or congenital cardiomyopathies: for the sake of
comparison, a 40% increase in diastolic Ca2þ levels was
measured in CMs from patients with hypertrophic cardio-
myopathy as compared with control cells (75). Such an
increase is sufficient to predispose CMs to contractile
dysfunction and the occurrence of arrhythmogenic mecha-
nisms (74). Accordingly, action potential recordings in
mouse ventricular myocytes exposed to TTR aggregates
showed a remarkable prolongation of repolarization with
a pronounced increase of the plateau level. Both events
are suggestive of increased cytosolic Ca2þ levels, in agree-
ment with our findings regarding TTR aggregate-induced2036 Biophysical Journal 111, 2024–2038, November 1, 2016Ca2þ accumulation and with previous studies in isolated
CMs (76).CONCLUSION
Taken together, our results indicate that alterations of
the mechanisms that control intracellular Ca2þ homeostasis
and prolong the duration of the action potential may alter the
functional properties of CMs, favoring the development
of cellular arrhythmias. In addition to further supporting
the idea that specific cellular abnormalities are induced
by TTR aggregates in the heart parenchyma, these effects
may also represent a basis for the occurrence of rhythm dis-
turbances and conduction alterations often seen in patients
with TTR amyloidosis.SUPPORTING MATERIAL
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